Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial

BACKGROUND: Anthracycline-induced cardiotoxicity has a variable incidence, and the development of left ventricular dysfunction is preceded by elevations in cardiac troponin concentrations. Beta-adrenergic receptor blocker and renin-angiotensin system inhibitor therapies have been associated with mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriksen, Peter A., Hall, Peter, MacPherson, Iain R., Joshi, Shruti S., Singh, Trisha, Maclean, Morag, Lewis, Steff, Rodriguez, Aryelly, Fletcher, Alex, Everett, Russell J., Stavert, Harriet, Broom, Angus, Eddie, Lois, Primrose, Lorraine, McVicars, Heather, McKay, Pam, Borley, Annabel, Rowntree, Clare, Lord, Simon, Collins, Graham, Radford, John, Guppy, Amy, Williams, Michelle C., Japp, Alan, Payne, John R., Newby, David E., Mills, Nicholas L., Oikonomidou, Olga, Lang, Ninian N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655910/
https://www.ncbi.nlm.nih.gov/pubmed/37746692
http://dx.doi.org/10.1161/CIRCULATIONAHA.123.064274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655910/
https://www.ncbi.nlm.nih.gov/pubmed/37746692
http://dx.doi.org/10.1161/CIRCULATIONAHA.123.064274

Ejemplares similares